For patients with cirrhosis at high risk of developing HCC, screening with an ultrasound of the liver and serum alpha fetoprotein (AFP) is recommended every 6 months [10,11,12,13,14,15,16,17]. Here, AFP is linked to hepatocellular carcinoma.